NC527-X

· Zhejiang Cancer Hospital

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NC527-X, covering 2026-04-20 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: A Phase II Clinical Study Evaluating the Effectiveness of Injectable NC527-X in Intraoperative Imaging for Patients With Solid Tumors [Phase 1]

See pricing